Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
Extending coverage for the medications through Medicare could cost $35 billion over nine years, a congressional analysis ...
With two new lawsuits, Eli Lilly (NYSE: LLY) has escalated its legal campaign against the makers of unauthorized versions of ...
Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback